J Neurocrit Care.  2017 Dec;10(2):140-142. 10.18700/jnc.170028.

Massive Extra-Ischemic Hemorrhage after Intravenous Thrombolysis in a Patient with Malignancy

• Park SJ
• Oh JH

• KMID: 2405773
• DOI: http://doi.org/10.18700/jnc.170028

Abstract

No abstract available.

MeSH Terms

Hemorrhage*
Humans

Figure

• 

  Figure 1. Brain magnetic resonance images and magnetic resonance angiography (MRA). Acute infarction in the right striatocapsular region is shown on the diffusion image (A). A multifocal small infarction in the bilateral cerebral hemisphere is also shown on both the diffusion (B) and fluid attenuated inversion recovery images (C). The brain MRA shows a nearly occluded right middle cerebral artery (D).

• 

  Figure 2. Brain magnetic resonance susceptibility weighted imaging after intravenous thrombolysis showing massive intracranial hemorrhage in the bilateral parietal lobes.

Reference

1. Balami JS, Sutherland BA, Buchan AM. Complications associated with recombinant tissue plasminogen activator therapy for acute ischaemic stroke. CNS Neurol Disord Drug Targets. 2013; 12:155–69.

2. National Institute of Neurological Disorders and Stroke rt-PA Stroke Study Group. Tissue plasminogen activator for acute ischemic stroke. N Engl J Med. 1995; 333:1581–7.

3. Trouillas P, von Kummer R. Classification and pathogenesis of cerebral hemorrhages after thrombolysis in ischemic stroke. Stroke. 2006; 37:556–61.

4. Bang OY, Seok JM, Kim SG, Hong JM, Kim HY, Lee J, et al. Ischemic stroke and cancer: stroke severely impacts cancer patients, while cancer increases the number of strokes. J Clin Neurol. 2011; 7:53–9.

5. Masrur S, Abdullah AR, Smith EE, Hidalgo R, El-Ghandour A, Rordorf G, et al. Risk of thrombolytic therapy for acute ischemic stroke in patients with current malignancy. J Stroke Cerebrovasc Dis. 2011; 20:124–30.

6. Murthy SB, Karanth S, Shah S, Shastri A, Rao CP, Bershad EM, et al. Thrombolysis for acute ischemic stroke in patients with cancer: a population study. Stroke. 2013; 44:3573–6.

7. Dzialowski I, Hill MD, Coutts SB, Demchuk AM, Kent DM, Wunderlich O, et al. Extent of early ischemic changes on computed tomography (CT) before thrombolysis: prognostic value of the Alberta Stroke Program Early CT Score in ECASS II. Stroke. 2006; 37:973–8.

8. Whiteley WN, Slot KB, Fernandes P, Sandercock P, Wardlaw J. Risk factors for intracranial hemorrhage in acute ischemic stroke patients treated with recombinant tissue plasminogen activator: a systematic review and meta-analysis of 55 studies. Stroke. 2012; 43:2904–9.

9. Mazya MV, Ahmed N, Ford GA, Hobohm C, Mikulik R, Nunes AP, et al. Remote or extraischemic intracerebral hemorrhage-an uncommon complication of stroke thrombolysis: results from the safe implementation of treatments in stroke-international stroke thrombolysis register. Stroke. 2014; 45:1657–63.

10. Ikeda H, Enatsu R, Yamana N, Nishimura M, Saiki M. Multiple extra-ischemic hemorrhages following intravenous thrombolysis in a patient with Trousseau syndrome: case study. Springerplus. 2015; 4:141.

11. Sun LM, Wu JN, Lin CL, Day JD, Liang JA, Liou LR, et al. Infective endocarditis and cancer risk: a population-based cohort study. Medicine (Baltimore). 2016; 95:e3198.

12. Asaithambi G, Adil MM, Qureshi AI. Thrombolysis for ischemic stroke associated with infective endocarditis: results from the nationwide inpatient sample. Stroke. 2013; 44:2917–9.